Marc Vandermeeren

1.6k total citations
20 papers, 1.2k citations indexed

About

Marc Vandermeeren is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Marc Vandermeeren has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Physiology and 5 papers in Cell Biology. Recurrent topics in Marc Vandermeeren's work include Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (3 papers) and Microtubule and mitosis dynamics (3 papers). Marc Vandermeeren is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (3 papers) and Microtubule and mitosis dynamics (3 papers). Marc Vandermeeren collaborates with scholars based in Belgium, United States and Netherlands. Marc Vandermeeren's co-authors include Marc Mercken, Jan Six, A. Van de Voorde, Jean‐Jacques Martin, Patrick Cras, Eugeen Vanmechelen, Ursula Lübke, J. Gheuens, Sophie Janssens and Μ. Borgers and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Neurochemistry.

In The Last Decade

Marc Vandermeeren

20 papers receiving 1.2k citations

Peers

Countries citing papers authored by Marc Vandermeeren

Since Specialization

Citations

This map shows the geographic impact of Marc Vandermeeren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Vandermeeren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Vandermeeren more than expected).

Fields of papers citing papers by Marc Vandermeeren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Vandermeeren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Vandermeeren. The network helps show where Marc Vandermeeren may publish in the future.

Co-authorship network of co-authors of Marc Vandermeeren

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Vandermeeren. A scholar is included among the top collaborators of Marc Vandermeeren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Vandermeeren. Marc Vandermeeren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology 2024 ·Frontiers in Aging Neuroscience ·(unknown), Kristof Van Kolen, Marc Vandermeeren, Pei‐Yu Shih, (unknown), (unknown), (unknown), Karolien Grauwen, Filip Van Hauwermeiren, Nina Van Opdenbosch, Mohamed Lamkanfi, Geert Loo, Astrid Bottelbergs	5
2	Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid 2023 ·Journal of Alzheimer s Disease ·(unknown), Marc Vandermeeren, Kristof Van Kolen, (unknown), M. Borgers, Cindy Wintmolders, Charlotte Delay, Astrid Bottelbergs, Marc Mercken, Clara Theunis	1
3	Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice 2021 ·Neurobiology of Disease ·Jonathan Janssens, Bart Hermans, Marc Vandermeeren, Erio Barale-Thomas, M. Borgers, Roland Willems, (unknown), Cindy Wintmolders, (unknown), Astrid Bottelbergs, Luc Ver Donck, Peter H. Larsen, Dieder Moechars, Wilson B. Edwards, Marc Mercken, Bianca Van Broeck	12
4	[P4–047]: ANTI‐TAU ANTIBODY PROFILING FOR PASSIVE IMMUNIZATION THERAPY: COMPARING SEEDS DERIVED FROM TRANSGENIC ANIMALS AND HUMAN BRAIN TISSUE 2017 ·Alzheimer s & Dementia ·M. Borgers, (unknown), Inez Van de Weyer, (unknown), (unknown), Marc Vandermeeren, Kristof Van Kolen, Greet Vanhoof, Andreas Ebneth, Marc Mercken	1
5	Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti‐tau antibody AT8 2016 ·Proteins Structure Function and Bioinformatics ·T. Malia, A. Teplyakov, Robin Ernst, Sheng‐Jiun Wu, Eilyn R. Lacy, Xuesong Liu, Marc Vandermeeren, Marc Mercken, Jinquan Luo, Raymond W. Sweet, Gary L. Gilliland	84
6	Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads 2010 ·Bioorganic & Medicinal Chemistry Letters ·Yifang Huang, (unknown), Chih Y. Ho, Charles H. Reynolds, Kelly A. Conway, Jennifer Piesvaux, Douglas E. Brenneman, George J. Yohrling, H. Moore Arnold, Daniel I. Rosenthal, Richard Alexander, Brett A. Tounge, Marc Mercken, Marc Vandermeeren, Michael H. Parker, Allen B. Reitz, Ellen W. Baxter	21
7	Reduction of Aβ Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for Aβ Production Inhibitors 2006 ·Current Pharmaceutical Design ·Mohammed El Mouedden, Marc Vandermeeren, Theo Meert, Marc Mercken	28
8	Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides 2005 ·Journal of Neuroscience Methods ·Mohammed El Mouedden, Marc Vandermeeren, Theo Meert, Marc Mercken	9
9	The functional γ-secretase inhibitor prevents production of amyloid β 1–34 in human and murine cell lines 2001 ·Neuroscience Letters ·Marc Vandermeeren, Martine Geraerts, Stefan Pype, Lieve Dillen, Carl Van Hove, Marc Mercken	36
10	Dimethylfumarate is an Inhibitor of Cytokine-Induced Nuclear Translocation of NF-κB1, But Not RelA in Normal Human Dermal Fibroblast Cells 2001 ·Journal of Investigative Dermatology ·Μ. Borgers, Rudi Beyaert, (unknown), Marc Vandermeeren, (unknown), (unknown), Sophie Janssens	70
11	Biological activity of hexitol nucleic acids targeted at Ha-ras and intracellular adhesion molecule-1 mRNA 2000 ·Biochemical Pharmacology ·Marc Vandermeeren, Sandra Prévéral, Sophie Janssens, Johan Geysen, (unknown), Arthur Van Aerschot, Piet Herdewijn	17
12	Retinoic Acid Potentiates TNF-α-Induced ICAM-1 Expression in Normal Human Epidermal Keratinocytes 1999 ·Biochemical and Biophysical Research Communications ·Sophie Janssens, (unknown), Marc Vandermeeren, Guy Daneels, Μ. Borgers, Johan Geysen	10
13	Dimethylfumarate Is an Inhibitor of Cytokine-Induced E-Selectin, VCAM-1, and ICAM-1 Expression in Human Endothelial Cells 1997 ·Biochemical and Biophysical Research Communications ·Marc Vandermeeren, Sophie Janssens, Μ. Borgers, Johan Geysen	133
14	The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament tau epitope in human LA-N-5 neuroblastoma cells 1993 ·Neuroscience Letters ·Marc Vandermeeren, (unknown), Jan Six, Patrick Cras	21
15	Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay 1993 ·Journal of Neurochemistry ·Marc Vandermeeren, Marc Mercken, Eugeen Vanmechelen, Jan Six, A. Van de Voorde, Jean‐Jacques Martin, Patrick Cras	401
16	Immunocytochemical detection of the growth‐associated protein B‐50 by newly characterized monoclonal antibodies in human brain and muscle 1992 ·Journal of Neurobiology ·Marc Mercken, Ursula Lübke, Marc Vandermeeren, J. Gheuens, A.B. Oestreicher	58
17	Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes 1992 ·Acta Neuropathologica ·Marc Mercken, Marc Vandermeeren, Ursula Lübke, Jan Six, Jef Boons, A. Van de Voorde, Jean‐Jacques Martin, J. Gheuens	301
18	Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases 1991 ·Brain Research ·J. Gheuens, Patrick Cras, George Perry, Jef Boons, (unknown), Ursula Lübke, Marc Mercken, Massimo Tabaton, (unknown), Marc Vandermeeren, Paul Mulvihill, Sandra L. Siedlak, (unknown), J. J. Martin	15
19	Isolation of IgG1-secreting switch variants from IgM hybridomas produced after in vitro immunization 1991 ·Journal of Immunological Methods ·Marc Mercken, Marc Vandermeeren, Ursula Lübke, Jef Boons, A. Van de Voorde, J. Gheuens	5
20	Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products 1989 ·Cellular Immunology ·Wim E.J. Weber, Marc Vandermeeren, Jef C.M. Raus, Wim A. Buurman	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact